Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:alsoKnownAs |
Poly IC:LC
|
| gptkbp:CASNumber |
31852-29-6
|
| gptkbp:chemicalClass |
synthetic double-stranded RNA
|
| gptkbp:clinicalTrialPhase |
gptkb:Phase_I
Phase II |
| gptkbp:developedBy |
Oncovir, Inc.
|
| gptkbp:mechanismOfAction |
TLR3 agonist
|
| gptkbp:routeOfAdministration |
subcutaneous
intravenous intranasal |
| gptkbp:usedFor |
immunostimulant
|
| gptkbp:usedIn |
gptkb:immunotherapy
gptkb:vaccine infectious disease research |
| gptkbp:bfsParent |
gptkb:Oncovir
|
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
Hiltonol
|